Magnesium-Doped Hydroxyapatite for Enhanced Biocompatibility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional hydroxyapatite biomaterials used in applications such as food additives, cosmetic ingredients, and artificial bones lack the high biocompatibility required for advanced applications.

Innovation Solution

Hydroxyapatite containing magnesium (Mg) with microcrystalline structure and optionally including minerals like Na, K, and Si, formulated using biologically derived materials to enhance biocompatibility and adsorption capacity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional hydroxyapatite is used, then it provides basic biocompatibility, but it lacks the high biocompatibility required for advanced applications

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidsuitability for advanced applications
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical composition parameters of hydroxyapatite by incorporating magnesium ions (Mg2+) at specific concentrations (1-3 atomic percent), which transforms the material from having basic biocompatibility to exhibiting high biocompatibility suitable for advanced medical applications

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite hydroxyapatite material by combining calcium hydroxyapatite with magnesium ions, forming a Mg-doped hydroxyapatite composite that exhibits enhanced biocompatibility and osteogenic properties not present in conventional hydroxyapatite

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If hydroxyapatite is made with microcrystalline structure, then adsorption capacity increases, but manufacturing complexity increases

Engineering Contradiction:
Improveadsorption capacityVSAvoidmanufacturing complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent controls the crystalline structure parameters by controlling particle size and crystallinity during synthesis, creating a microcrystalline structure that maximizes surface area and adsorption capacity while using optimized synthesis conditions to manage manufacturing complexity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Mg-containing hydroxyapatite exhibits higher biocompatibility and adsorption capacity, suitable for applications like filter materials and teeth whitening, with improved safety and reduced irritation due to its fine particle size and smooth texture.

Implementation Method 1

hydroxyapatite containing Mg... (Ca:Mg)10(PO4)6(OH)2 wherein (Ca:Mg)10 denotes that the total number of Ca atoms and Mg atoms equals to 10, with the number of Ca atoms being from 7 to 9, and the number of Mg atoms being from 1 to 3

Methodology Applied
Scientific EffectIon substitution:

Implementation Method 2

a site for inducing precipitation of hydroxyapatite crystals is incorporated into a substrate and the substrate is immersed in an aqueous solution containing a hydroxyapatite component, to thereby precipitate hydroxyapatite crystals on the surface of the substrate

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 3

a substrate is coated or printed by predetermined hydroxyapatite dispersion, and then the solvent contained in the hydroxyapatite dispersion is evaporated from the substrate to thereby generate low crystalline hydroxyapatite particles on the surface of the substrate

Methodology Applied
Scientific EffectEvaporation: Evaporation

Data Source

PatentUS20210094825A1hydroxyapatite
Publication Date: 2021.04.01 BIOAPATITE KK
  • US20210094825A1 patent drawing

AI summary

Hydroxyapatite having high biocompatibility suitable for applications such as food additives, cosmetic ingredients, pharmaceutical ingredients, and artificial bones is provided. The hydroxyapatite of the present invention contains Mg.